Detalhe da pesquisa
1.
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
N Engl J Med
; 388(18): 1657-1667, 2023 May 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37133585
2.
[Morphological and immunophenotypical confrontation in the diagnosis of a rare gastric tumor]. / Confrontation morphologique et immunophénotypique pour le diagnostic d'une tumeur gastrique rare.
Ann Pathol
; 44(1): 78-81, 2024 Feb.
Artigo
Francês
| MEDLINE | ID: mdl-37659879
3.
Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial.
Dig Liver Dis
; 2024 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38762353
4.
Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial.
Eur J Cancer
; 162: 161-169, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34998048
5.
MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer.
Clin Res Hepatol Gastroenterol
; 46(5): 101888, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35189426
6.
Three cases of immune cholangitis related to anti-programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer.
Eur J Cancer
; 115: 107-110, 2019 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-31132740